Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-005681

Chairman, President & CEO sold 164,443 shares at an average $103.69 ($17,051,136)

  • Chairman, President & CEO acquired 105,619 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mahoney Michael F Chairman, President & CEO 2025-06-02 Option exercise 10b5-1 +56,212 $17.26 $970,219 1,591,918 D: show line 1 in the form
Mahoney Michael F Chairman, President & CEO 2025-06-02 Option exercise 10b5-1 +49,407 $24.55 $1,212,942 1,641,325 D: show line 2 in the form
Mahoney Michael F Chairman, President & CEO 2025-06-02 Sale 10b5-1 −74,522 $104.05 $7,754,186 1,566,803 D: show line 3 in the form
Mahoney Michael F Chairman, President & CEO 2025-06-02 Sale 10b5-1 −89,921 $103.39 $9,296,950 1,476,882 D: show line 4 in the form
Open-market sales · 164,443 sh · avg $103.69 · $17,051,136

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mahoney Michael F Chairman, President & CEO 2025-06-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −56,212 0 D: show line 5 in the form
Mahoney Michael F Chairman, President & CEO 2025-06-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −49,407 148,221 D: show line 6 in the form
Loading xslF345X05/doc4.xml…